Skip to main content
Clinical Trials/NCT03324919
NCT03324919
Completed
Not Applicable

Patient Centered Care Situation and Health-related Quality of Life of Patients From Non-urban Practice vs University Hospital With Diagnosis Psoriasis Vulgaris, Urticaria or Lupus Erythematodes

University Hospital Regensburg1 site in 1 country220 target enrollmentMarch 1, 2016
ConditionsQuality of Life

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Quality of Life
Sponsor
University Hospital Regensburg
Enrollment
220
Locations
1
Primary Endpoint
Investigation of patient centered care situation and health-related quality of life of patients with Psoriasis, Urtikaria and Lupus erythematosus
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study is based on a survey about the patient centered care situation and health-related quality of life of patients with diagnoses Psoriasis, Urtikaria or Lupus erythematodes. Detection of relevant parameters of quality of life by these patients serves for the detection of psychosocial burden of the mentioned skin diseases, thus gaining an increasing importance for prospective economic issues. This survey is a behaviorally based questionnaire for patients with the above diseases and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behavior, social interaction, and the like.

Detailed Description

The care of patients with the above indications is based on a wide variety of available therapies. This study is based on a survey about the patient centered care situation and health-related quality of life of patients with diagnoses Psoriasis, Urtikaria or Lupus erythematodes. Therefore a cross-sectional survey will be done of patients with the above diseases from non-urban practices vs. urban practices (University Hospital). An adequate diagnosis and treatment of Psorisasis, Urticaria or Lupus erythematodes is often problematic due to the diverse and complex organ manifestations. However adequate diagnosis and appropriate treatments of these diseases is often conducted by various medical specialists in both outpatient and in-patient care. Lack of access and ability of the rural population to get an appropriate therapy may lead by these patients to false diagnosis or a therapeutic oversupply of an only symptom-oriented therapy. Furthermore the partly chronic character in the above mentioned diseases with recurrent symptoms, connected with prolonged itching periods and long-lasting treatments by these patients can lead to both emotional, mental stress and physical isolation. This situation does not only affect the health but also the overall quality of life of these patients. Therefore this study addresses several factors concerning the patient's perceived health status and to detect changes or differences in health status occurring between groups (patients from non-urban practices vs urban practices)

Registry
clinicaltrials.gov
Start Date
March 1, 2016
End Date
September 1, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tim Maisch

PD Dr.

University Hospital Regensburg

Eligibility Criteria

Inclusion Criteria

  • Voluntary consent by written and oral explanation.
  • Patients with the diseases Psoriasis, Urticaria or Lupus

Exclusion Criteria

  • Children and adolescents \< 18 years
  • pregnancy and breast feeding period of women
  • History of abuse of alcohol, drugs or other substances, or factors that limit the ability to cooperate and compliance in the study

Outcomes

Primary Outcomes

Investigation of patient centered care situation and health-related quality of life of patients with Psoriasis, Urtikaria and Lupus erythematosus

Time Frame: 24 months

Detection of the quality of life score by these patients. Questionnaire administration and clinical documentation takes place when patients were present at the outpatient clinic of the Department of Dermatology, University Hospital Regensburg. Key inclusion criteria: diagnoses of psoriasis, urticaria or lupus erythematodes

Secondary Outcomes

  • Identification of relevant health-related quality of life parameters of these patients(24 months)
  • Evalulation of the EQ5D-5L score of patients with Psoriasis, Urtikaria and Lupus erythematosus(24 months)

Study Sites (1)

Loading locations...

Similar Trials